Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Altimmune Inc
(NQ:
ALT
)
6.550
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Altimmune Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
3 Undervalued Biotech Stocks With Breakout Potential
Today 6:00 EDT
Invest in these three undervalued biotech stocks with double-digit upside ahead driven by cutting-edge healthcare advancements
Via
InvestorPlace
Forget Boring Diversification! 3 Wild-Card Stocks to Spice Up Your Portfolio
July 17, 2024
These three wild-card stocks will spice up your portfolio in ways boring diversification never could, so read on.
Via
InvestorPlace
Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics
July 10, 2024
Both competitors have promising lead programs, and enough cash, too.
Via
The Motley Fool
7 Bullish Stock Picks With the Potential to Turn $5K Into $50K
July 09, 2024
These high-potential stock picks each have 10X potential moving forward and are well worth understanding despite high prices in some cases.
Via
InvestorPlace
The 7 Best Under $10 Stocks to Buy in July 2024
July 06, 2024
We’re finding big opportunities in some of the best stocks under $10 a share. In fact, here are seven you may want to jump into now.
Via
InvestorPlace
Forecasting The Future: 5 Analyst Projections For Altimmune
June 21, 2024
Via
Benzinga
How Is The Market Feeling About Altimmune?
June 03, 2024
Via
Benzinga
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics
June 30, 2024
While their share prices have traveled different paths recently, the similarity between the two companies is striking.
Via
The Motley Fool
If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy
June 29, 2024
The market for weight loss medicines keeps getting hotter and hotter.
Via
The Motley Fool
The 3 Smartest Biotech Stocks to Buy With $5K Right Now
June 28, 2024
With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs.
Via
InvestorPlace
Why Are Altimmune Shares Trading Lower Wednesday?
June 26, 2024
Altimmune shares are experiencing significant movement lower following the unexpected passing of Richard Eisenstadt, the company's Chief Financial Officer.
Via
Benzinga
Why Is Alimera Sciences (ALIM) Stock Up 77% Today?
June 24, 2024
Alimera Sciences stock is up on Monday as investors react to a $5.50 per share acquisition offer for ALIM from ANI Pharmaceuticals.
Via
InvestorPlace
BITF Stock Alert: Riot Platforms Is Changing Its Approach to Take Over Bitfarms
June 24, 2024
Bitfarms stock is down on Monday after Riot Platforms withdrew its offer for BITF stock in favor of nominating new board memebers.
Via
InvestorPlace
ALT Stock Earnings: Altimmune Beats EPS for Q1 2024
May 09, 2024
ALT stock results show that Altimmune beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Peering Into Altimmune's Recent Short Interest
April 30, 2024
Via
Benzinga
ALT Stock Alert: Altimmune Pops on Weight-Loss Drug Findings
June 24, 2024
Altimmune (ALT) stock is soaring and trending after the company reported data on its GLP-1 weight-loss drug today.
Via
InvestorPlace
Altimmune Stock Is Rising Monday: What's Driving The Action?
June 24, 2024
Altimmune said it presented data from the 48-week Phase 2 MOMENTUM clinical trial of pemvidutide, including the results of a recently completed body composition analysis at the American Diabetes...
Via
Benzinga
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
June 24, 2024
Via
Benzinga
3 Stocks Under $10 Set to Quadruple by 2025: June Edition
June 13, 2024
Low-priced stocks under $10 can be explosively awarding if you spot the right one at the right time with the right catalyst.
Via
InvestorPlace
3 Stocks Quietly Preparing for a 10X Surge: June Edition
June 12, 2024
There are plenty of 10x stocks with the potential to surge 10x over. We’ve already seen in happen with Apple, Netflix, Microsoft and Nvidia.
Via
InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
June 04, 2024
https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate
Via
InvestorPlace
The Penny Stock Prophecy: 3 Overlooked Stocks Primed to Pop
May 27, 2024
Overlooked penny stocks are the path to outsized gains and these shares seem to fit the bill at the moment.
Via
InvestorPlace
3 Monster Stocks in the Making You Can Buy Right Now
May 18, 2024
These stocks might not be small for too much longer.
Via
The Motley Fool
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
May 17, 2024
With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead.
Via
InvestorPlace
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
May 09, 2024
The second wave of the weight loss drug stock boom is underway and investors should heed the signs the market is serving.
Via
InvestorPlace
Jim Cramer Calls Nutanix 'The Perfect Enterprise Software Company For The Moment'
May 07, 2024
Cramer discusses Agnico Eagle Mines, Nutanix, Altimmune, CVR Energy and Quanta Services on CNBC's "Mad Money."
Via
Benzinga
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 29, 2024
Via
Benzinga
Deutsche Bank, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
April 29, 2024
Via
Benzinga
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
April 24, 2024
These weight loss drug stocks are relatively unknown and brimming with potential following the massive success of Novo Nordisk and Eli Lilly.
Via
InvestorPlace
Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential
April 20, 2024
Altimmune has a modest market cap but an incredibly promising GLP-1 drug.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.